Liminal BioSciences Inc. Common Shares
LMNL
LMNL was delisted on the 25th of September, 2023.
14 hedge funds and large institutions have $36.8M invested in Liminal BioSciences Inc. Common Shares in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
63% more capital invested
Capital invested by funds: $22.6M → $36.8M (+$14.2M)
27% more funds holding
Funds holding: 11 → 14 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Atom Investors
Austin,
Texas
|
+$217K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$99.9K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$38K |
| 4 |
Morgan Stanley
New York
|
+$13.4K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$1.33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$16K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$13.1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.65K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
1
Consonance Capital Management
New York
| $35.4M | – | – | – |
|
|
FDCDDQ
2
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $415K | +$1.33K | +15 | +0.4% |
|
|
3
Morgan Stanley
New York
| $394K | +$13.4K | +152 | +4% |
|
|
AI
4
Atom Investors
Austin,
Texas
| $265K | +$217K | +2,455 | New |
|
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $143K | +$38K | +430 | +48% |
|
|
6
Citadel Advisors
Miami,
Florida
| $118K | +$99.9K | +1,130 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $7K | -$2.65K | -30 | -30% |
|
8
Bank of Montreal
Toronto,
Ontario, Canada
| $4K | – | – | – |
|
|
RE
9
RBC Europe
London,
United Kingdom
| $2.53K | – | – | – |
|
10
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $1K | +$884 | +10 | +333% |
|
11
Bank of America
Charlotte,
North Carolina
| $1K | +$1.15K | +13 | New |
|
|
12
JP Morgan Chase
New York
| – | -$16K | -245 | Closed |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$13.1K | -148 | -99% |
|
|
CFG
14
Citizens Financial Group
Providence,
Rhode Island
| – | +$177 | +2 | New |
|
LMNL Hedge Fund Activity: Q2 2020 in Review
14 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Liminal BioSciences Inc. Common Shares (LMNL) for Q2 2020, worth a combined $36.8M — up 63% from $22.6M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new LMNL positions and 1 closed out — a net gain of 3 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Atom Investors, opening a new position worth an estimated $217K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $16K sold.
- 14 institutional investors held Liminal BioSciences Inc. Common Shares (LMNL) as of Q2 2020, up from 11 in Q1 2020.
- Funds reported $36.8M of Liminal BioSciences Inc. Common Shares stock for Q2 2020, up 63% quarter-over-quarter.
- 4 funds opened new Liminal BioSciences Inc. Common Shares positions in Q2 2020 and 1 closed out, a net change of +3 holders.
- The largest Liminal BioSciences Inc. Common Shares buyer in Q2 2020 was Atom Investors, an estimated $217K added.
- The largest Liminal BioSciences Inc. Common Shares seller in Q2 2020 was JP Morgan Chase, an estimated $16K sold.
Based on aggregated 13F filings for Q2 2020.